Orange Book product · Generic (ANDA)
LACTULOSE
LACTULOSE
At a glance
Jul 03, 1995
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 03, 1995
31 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
LACTULOSE
Strength
10GM/15ML
Dosage form
SOLUTION
Route
ORAL, RECTAL
TE code
Not listed
Application
ANDA 074077
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LACTULOSE
- —CHRONULACBrand (NDA)
NDA 017884 · SANOFI AVENTIS US
- —CEPHULACBrand (NDA)
NDA 017657 · SANOFI AVENTIS US
- —LACTULOSEBrand (NDA)
NDA 017906 · SOLVAY
- 2025LACTULOSEGeneric (ANDA)
ANDA 217914 · PAI HOLDINGS
- 2024LACTULOSEGeneric (ANDA)
ANDA 218858 · TARO
- 2018LACTULOSEGeneric (ANDA)
ANDA 209517 · CHARTWELL RX
- 2018LACTULOSEGeneric (ANDA)
ANDA 207786 · APOZEAL PHARMS
- 2015LACTULOSEGeneric (ANDA)
ANDA 203762 · SCIEGEN PHARMS
- 2012LACTULOSEGeneric (ANDA)
ANDA 090503 · FRESENIUS KABI
- 2012LACTULOSEGeneric (ANDA)
ANDA 090502 · FRESENIUS KABI
- 2008LACTULOSEGeneric (ANDA)
ANDA 090426 · ANI PHARMS
- 2007LACTULOSEGeneric (ANDA)
ANDA 078430 · ANI PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
